跳至主要内容
临床试验/NCT03640793
NCT03640793已完成不适用

Prospective Evaluation of a Palato-Pharyngeal Implant System (PPIS) for the Treatment of Snoring and Obstructive Sleep Apnea Syndrome (OSAS): a Pilot Study

Medartis AG2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2017年10月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Medartis AG
入组人数
25
试验地点
2
主要终点
AHI reduction

研究概览

简要总结

Prospective Evaluation of a Palato-Pharyngeal Implant System (PPIS) for the Treatment of Snoring and Obstructive Sleep Apnea Syndrome (OSAS): A Pilot Study.

详细描述

The clinical study is designed as single center, prospective, non-randomized and non-blinded clinical study. Since the surgical procedure is independent of the population a single center study is applied. A double-blind study is not possible considering the implantation procedure with the surgeon always knowing if the device is set. Therefore, the study is designed to be non-randomized and non-blinded as a pilot trial.

To reduce bias and other influences of single surgeon skills a principal investigator and one investigator are part of the clinical study. Further, subjects with previous treatments such as Pillar implant or previous airway surgery other than nasal, adenoid, tonsil or UPPP are excluded from the clinical study. A double-blind study is not possible considering the implantation procedure with the surgeon always knowing if the device is set. Therefore, the study is designed to be non-randomized and non-blinded as a pilot trial.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • • Socially disturbing snoring and obstructive sleep apnea syndrome with AHI≥10/h
  • Predominantly retropalatal obstructions established either by:
  • Drug-induced sedation nasendoscopy
  • or ApneaGraph ≥60% (optional)
  • or successful application of the Velumount palatal device (optional)
  • Findings for predominantly retropalatal obstructions in ENT-examination:
  • No tonsils or tonsils grade I
  • Normal finding of larynx and tongue base, no omega-shaped epiglottis
  • No lingual tonsil hypertrophy
  • ASA (American Society of Anaesthesiology, 1963) classes I or II
  • Body mass index (BMI) < 30 kg/m2
  • Age > 18 yrs
  • Fix bed partner
  • Ability to read and understand the patient's information

排除标准

  • • Previous Pillar implants
  • Medartis palatinal implant (from previous phase I study)
  • Previous airway surgery other than nasal, adenoid, tonsil or UPPP
  • Presence of other sleep disorders
  • Psychiatric disorders
  • Neurological disorders (e.g. Cerebrovascular injury)
  • Dysmorphia of the cranial skeleton
  • Pregnancy or breastfeeding
  • Known hypersensitivity to nitinol
  • Participation in another clinical study
  • Recurrent tonsillitis with prescription of antibiotics during the last 2 years (≥3x/year)
  • Omega-shaped epiglottis
  • Lingual tonsil hypertrophy
  • Kinking of the internal carotid artery

研究组 & 干预措施

Single center, prospective, non-randomized, non-blinded study

Experimental

Implantation of 6 PPIS implants in each patient

干预措施: Implantation (Device)

结局指标

主要结局

AHI reduction

时间窗: 3 months post-op

AHI reduction

次要结局

未报告次要终点

研究者

发起方
Medartis AG
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验